Diagnosis and treatment of acute lymphoblastic leukemia in Latin America

References

• Pui CH, Yang JJ, Bhakta N, et al. Global efforts toward the cure of childhood acute lymphoblastic leukemia. Lancet Child Adolesc Health. 2018 Jun;2(6):440–454.
   PubMedGoogle Scholar
• Quiroz E, Aldoss I, Pullarkat V, et al. The emerging story of acute lymphoblastic leukemia among the Latin American population – biological and clinical implications. Blood Rev. 2019 Jan;33:98–105.
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. CONCORD working group. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018 Mar 17;391(10125):1023–1075.
   PubMed Web of Science ®Google Scholar
• Muñoz-Aguirre P, Huerta-Gutierrez R, Zamora S, et al. Acute lymphoblastic leukaemia survival in children covered by Seguro popular in Mexico: a national comprehensive analysis 2005–2017. Health Systems & Reform. 2021;7:1.
   Web of Science ®Google Scholar
• Pollyea DA, Kohrt HE, Yang J, et al. Acute leukemia in Hispanic Americans: incidence and incidence rate differences by nativity. Blood. 2012;120(21):3160–3160.
   Google Scholar
• Pinheiro Junior ED, Pracchia LF, Beitler de Maurino B, et al. Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study. Clin Lymphoma Myeloma Leuk. 2015;15:e7–e14.
   PubMedGoogle Scholar
• Gupta S, Antillon FA, Bonilla M, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer. 2011 Oct 15;117(20):4788–4795.
   PubMed Web of Science ®Google Scholar
• Swords R, Sznol J, Elias R, et al. Acute leukemia in adult Hispanic Americans: a large-population study. Blood Cancer J. 2016 Oct 14;6(10):e484–e484.
   PubMedGoogle Scholar
• Stiller CA. International patterns of cancer incidence in adolescents. Cancer Treat Rev. 2007 Nov;33(7):631–645.
   PubMed Web of Science ®Google Scholar
• Pérez-Saldivar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011 Aug 17;11:355.
   PubMed Web of Science ®Google Scholar
• Santamaría-Quesada C, Vargas M, Venegas P, et al. Molecular and epidemiologic findings of childhood acute leukemia in Costa Rica. J Pediatr Hematol Oncol. 2009 Feb;31(2):131–135.
   PubMed Web of Science ®Google Scholar
• Almanza-Huante E, Espinosa-Bautista K, Rangel-Patiño J, et al. Comparison of two pediatric-inspired regimens to hyper-CVAD in Hispanic adolescents and young adults with acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):55–62.e2.
   PubMed Web of Science ®Google Scholar
• Biondi A, Conter V, Chandy M, et al. Precursor B-cell acute lymphoblastic leukaemia—a global view. Br J Haematol. 2022 Feb;196(3):530–547.
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, van der Velden VH, Brüggemann M, et al. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies. Blood. 2015 Jun 25;125(26):3996–4009.
   PubMed Web of Science ®Google Scholar
• Hunger SP, Raetz EA. How I treat relapsed acute lymphoblastic leukemia in the pediatric population. Blood. 2020 Oct 15;136(16):1803–1812. doi:10.1182/blood.2019004043.
   PubMed Web of Science ®Google Scholar
• Silva WF, Silverio A, Duarte BKL, et al. Philadelphia-positive B-lymphoblastic leukemia in a middle-income country – a real-world multicenter cohort. Leuk Res. 2021 Nov;110:106666.
   PubMed Web of Science ®Google Scholar
• Linares Ballesteros A, Yunis LK, García J, et al. Philadelphia-like acute lymphoblastic leukemia: characterization in a pediatric cohort in a referral center in Colombia. Cancer Rep (Hoboken). 2021 Nov 17;5:e1587.
   PubMedGoogle Scholar
• Silva WF, Amano MT, Perruso LL, et al. Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation. Hematology. 2022 Dec;27(1):396–403.
   PubMed Web of Science ®Google Scholar
• Harvey RC, Mullighan CG, Chen I-M, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 2010;115:5312–5321.
   PubMed Web of Science ®Google Scholar
• Issa GC, Kantarjian HM, Yin CC, et al. Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease. Cancer. 2017 Feb 1;123(3):459–467.
   PubMed Web of Science ®Google Scholar
• Crespo-Solis E, Espinosa-Bautista K, Alvarado-Ibarra M, et al. Survival analysis of adult patients with ALL in Mexico City: first report from the acute leukemia workgroup (ALWG) (GTLA). Cancer Med. 2018 Jun;7(6):2423–2433.
   PubMed Web of Science ®Google Scholar
• Fernandes da Silva Junior W, Medina AB, Yamakawa PE, et al. Treating adult acute lymphoblastic leukemia in Brazil-increased early mortality using a German multicenter acute lymphoblastic leukemia-based regimen. Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):e255–e259.
   PubMed Web of Science ®Google Scholar
• Grant E, González-Montalvo P, Pantoja-Guillén F, et al. Treating childhood acute lymphoblastic leukemia in a country with no pediatric hematologist/oncologist: a Belize/Mérida joint venture. Blood Adv. 2018 Nov 30;2(Suppl 1):67–68. doi:10.1182/bloodadvances.2018GS112665.
   PubMedGoogle Scholar
• Howard SC, Davidson A, LunaFineman S, et al. A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middleincome countries: the pediatric oncology in developing countries (PODC) committee of the international pediatric oncology society (SIOP). Pediatr Blood Cancer. 2017;64:e26879. doi:10.1002/pbc.2687.
   Web of Science ®Google Scholar
• Oh BLZ, Lee SHR, Yeoh AEJ. Curing the curable: managing low-risk acute lymphoblastic leukemia in resource limited countries. J Clin Med. 2021 Oct 15;10(20):4728. doi:10.3390/jcm10204728.
   PubMed Web of Science ®Google Scholar
• Silva WFD, Rosa LID, Belesso M, et al. Treatment outcomes of adult Burkitt lymphoma: results with a modified LMB protocol in Brazil and feasibility of outpatient administration. J Chemother. 2018 Oct–Dec;30(6-8):375–379.
   PubMed Web of Science ®Google Scholar
• Jaime-Pérez JC, Jiménez-Castillo R, Herrera-Garza JL, et al. Survival rates of adults with acute lymphoblastic leukemia in a low-income population: a decade of experience at a single institution in Mexico. Clin Lymphoma Myeloma Leuk. 2017;17:60–68.
   PubMed Web of Science ®Google Scholar
• Portugal RD, Loureiro MM, Garnica M, et al. Feasibility and outcome of the hyper-CVAD regimen in patients with adult acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2015 Jan;15(1), 52–57.
   PubMed Web of Science ®Google Scholar
• Kantarjian H, Stein A, Gökbuget N, et al. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. N Engl J Med. 2017 Mar 2;376(9):836–847.
   PubMed Web of Science ®Google Scholar
• Kantarjian HM, DeAngelo DJ, Stelljes M, et al. Inotuzumab ozogamicin versus standard therapy for acute lymphoblastic leukemia. N Engl J Med. 2016 Aug 25;375(8):740–753.
   PubMed Web of Science ®Google Scholar
• Ravindranath A, Dubey A, Suresh S, et al. CAR-T cell therapy in India requires a paradigm shift in training, education and health care processes. Cytotherapy. 2022 Feb;24(2):101–109. doi:10.1016/j.jcyt.2021.09.007.
   PubMed Web of Science ®Google Scholar
• Guerino-Cunha RL, Clé D, Carvalho-Palma L, et al. Viability of chimeric antigen receptor T cell therapy in Latin America. Blood. 2021;138, doi:10.1182/blood-2021-154217.
   Google Scholar
• Pedrosa F, Coustan-Smith E, Zhou Y, et al. Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study. Blood. 2020 Apr 23;135(17):1458–1466.
   PubMed Web of Science ®Google Scholar
• Jaime-Pérez JC, Jiménez-Castillo RA, Pinzón-Uresti MA, et al. Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: results at a single center in Latin America. Pediatr Blood Cancer. 2017 Jul;64(7). doi:10.1002/pbc.26396.
   Web of Science ®Google Scholar
• Bajel A, George B, Mathews V, et al. Adult ALL: treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol. Leukemia. 2007 Oct;21(10):2230–2233.
   PubMed Web of Science ®Google Scholar
• Ladas EJ, Arora B, Howard SC, et al. A framework for adapted nutritional therapy for children with cancer in low- and middle-income countries: a report from the SIOP PODC nutrition working group. Pediatr Blood Cancer. 2016 Aug;63(8):1339–1348. doi:10.1002/pbc.26016.
   PubMed Web of Science ®Google Scholar
• Barr RD, Gomez-Almaguer D, Jaime-Perez JC, et al. Importance of nutrition in the treatment of leukemia in children and adolescents. Arch Med Res. 2016 Nov;47(8):585–592.
   PubMed Web of Science ®Google Scholar
• Lobato-Mendizábal E, Ruiz-Argüelles GJ, Marín-López A. Leukaemia and nutrition I: malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukaemia. Leuk Res. 1989;13(10):899–906.
   PubMed Web of Science ®Google Scholar
• Torres-Flores J, Espinoza-Zamora R, Garcia-Mendez J, et al. Treatment-related mortality from infectious complications in an acute leukemia clinic. J Hematol. 2020 Dec;9(4):123–131. doi:10.14740/jh751.
   PubMedGoogle Scholar
• Ribeiro RC, Pui CH. Saving the children—improving childhood cancer treatment in developing countries. N Engl J Med. 2005;352(21):2158–2160.
   PubMed Web of Science ®Google Scholar
• Atun R, Bhakta N, Denburg A, et al. Sustainable care for children with cancer: a Lancet oncology commission. Lancet Oncol. 2020 Apr;21(4):e185–e224. doi:10.1016/S1470-2045(20)30022-X.
   PubMed Web of Science ®Google Scholar
• Jaime-Pérez JC, Fernández LT, Jiménez-Castillo RA, et al. Hospitalization rate and costs in acute lymphoblastic leukemia of childhood in a low-income group: financial impact in northeast Mexico. Pediatr Blood Cancer. 2017 Dec;64(12). doi:10.1002/pbc.26673.
   Web of Science ®Google Scholar
• Colunga-Pedraza JE, González-Llano O, González-Martinez CE, et al. Outpatient low toxic regimen with bortezomib in relapsed/refractory acute lymphoblastic leukemia in pediatrics and AYA patients: single-center Mexican experience. Pediatr Blood Cancer. 2020 May;67(5):e28241.
   PubMed Web of Science ®Google Scholar
• Ruiz-Delgado GJ, Macías-Gallardo J, Lutz-Presno JA, et al. Outcome of adults with acute lymphoblastic leukemia treated with a pediatric-inspired therapy: a single institution experience. Leuk Lymphoma. 2011 Feb;52(2):314–316. doi:10.3109/10428194.2010.529202.
   PubMed Web of Science ®Google Scholar
• Intermesoli T, Krishnan S, MacDougall F, et al. Efficacy of an intensive post-induction chemotherapy regimen for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia, given predominantly in the outpatient setting. Ann Hematol. 2011 Sep;90(9):1059–1065.
   PubMed Web of Science ®Google Scholar
• Gomez-De Leon A, Varela-Constantino A, Colunga-Pedraza PR, et al. Effective treatment of Ph-negative acute lymphoblastic leukemia for uninsured Hispanic adolescents and young adults with a low-cost outpatient regimen. Blood. 2021;138(Supplement 1):4102–4102.
   Google Scholar
• Antillón FG, Blanco JG, Valverde PD, et al. The treatment of childhood acute lymphoblastic leukemia in Guatemala: biologic features, treatment hurdles, and results. Cancer. 2017 Feb 1;123(3):436–448.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Galindo C, Friedrich P, Alcasabas P, et al. Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol. 2015;33:3065–3073.
   PubMed Web of Science ®Google Scholar
• Are C, Berman RS, Wyld L, et al. Global curriculum in surgical oncology. Eur J Surg Oncol; 42(6):754–766.
   PubMed Web of Science ®Google Scholar